Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume -, Issue -, Pages 1-16
Publisher
Informa UK Limited
Online
2022-04-15
DOI
10.1080/14740338.2022.2066650
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The acute effects of classic psychedelics on memory in humans
- (2021) C. J. Healy PSYCHOPHARMACOLOGY
- Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
- (2021) Nicole L. Galvão-Coelho et al. PSYCHOPHARMACOLOGY
- The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
- (2021) Rafael Guimarães dos Santos et al. Risk Management and Healthcare Policy
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
- (2021) Friederike Holze et al. Frontiers in Pharmacology
- Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review
- (2021) Gniewko Więckiewicz et al. Pharmaceuticals
- Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
- (2020) Gabrielle I Agin-Liebes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy
- (2020) Rafael G. dos Santos et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- (2019) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
- (2018) Andrea Cipriani et al. LANCET
- The entropic brain - revisited
- (2018) Robin L. Carhart-Harris NEUROPHARMACOLOGY
- Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review
- (2018) Simon Reiche et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
- (2018) Fernanda Palhano-Fontes et al. PSYCHOLOGICAL MEDICINE
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
- (2018) Rafael G. dos Santos et al. Expert Review of Clinical Pharmacology
- Depression
- (2018) Gin S Malhi et al. LANCET
- Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy
- (2017) Paula Kopschina Feltes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
- (2016) Rafael Faria Sanches et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
- (2016) Frederick S Barrett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Meaning-Centered Group Psychotherapy: An Effective Intervention for Improving Psychological Well-Being in Patients With Advanced Cancer
- (2015) William Breitbart et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
- (2014) Peter Gasser et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
- (2014) Peter Gasser et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Headache may be caused by activation of 5-HT2A receptors in serotonin toxicity
- (2014) A. Alexander BMJ-British Medical Journal
- Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations
- (2013) M. Kometer et al. JOURNAL OF NEUROSCIENCE
- Association of Depression and Anxiety on Quality of Life, Treatment Adherence, and Prognosis in Patients with Advanced Non-small Cell Lung Cancer
- (2012) Óscar Arrieta et al. ANNALS OF SURGICAL ONCOLOGY
- Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
- (2011) Alex J Mitchell et al. LANCET ONCOLOGY
- Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
- (2011) Adam L. Halberstadt et al. NEUROPHARMACOLOGY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More